GoldMining Initiates New Exploration Drill Program
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy GLDG?
Source: Newsfilter
- Drill Program Launch: GoldMining has commenced an 8,000-meter drill program at its São Jorge Project in Brazil's Tapajós gold district, aimed at following up on high-priority targets from 2025, which is expected to significantly enhance mineral resource estimates.
- High-Priority Targets: The drilling will focus on the William South area, located 2 km from the existing deposit, with initial results indicating 2.38 g/t gold at a depth of 13 meters, suggesting substantial mineralization potential in the region.
- Geophysical Coverage Expansion: An ongoing IP survey covering 49 kilometers is significantly expanding existing geophysical coverage, further confirming surface geochemical anomalies in a 12 km by 7 km area surrounding the deposit, highlighting broader exploration potential.
- Infrastructure Advantage: The project area benefits from excellent infrastructure, including grid power, highway access, and a fully operational 50-person camp, allowing more funds to be directed towards the expansion of mineral resources.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GLDG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GLDG
Wall Street analysts forecast GLDG stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.100
Low
2.80
Averages
2.80
High
2.80
Current: 1.100
Low
2.80
Averages
2.80
High
2.80
About GLDG
GoldMining Inc. is a mineral exploration company focused on acquiring and developing gold assets in the Americas. It controls a diversified portfolio of resource-stage gold and gold-copper projects in Canada, the United States, Brazil, Colombia, and Peru. Its projects include Sao Jorge, Cachoeira, Boa Vista, Surubim, Batistao, Montes Aureos and Trinta, Whistler gold-copper, Nutmeg Mountain, Yellowknife Gold, Rea, La Mina, Titiribi, Yarumalito, and Crucero. The Titiribi project is a copper-gold exploration project located over 51 kilometers (km) from Medellin, Colombia. The La Mina project comprises two concessions covering over 3,208 hectares, located in the Department of Antioquia, Republic of Colombia. The Yellowknife Gold project is comprised of five properties: Ormsby - Bruce, Nicholas Lake, Goodwin Lake, Clan Lake, and Big Sky. Sao Jorge is a resource stage gold exploration project located 4 km west of the Cuiaba-Santarem Highway BR-163.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
GoldMining Initiates New Exploration Drill Program
- Drill Program Launch: GoldMining has commenced an 8,000-meter drill program at its São Jorge Project in Brazil's Tapajós gold district, aimed at following up on high-priority targets from 2025, which is expected to significantly enhance mineral resource estimates.
- High-Priority Targets: The drilling will focus on the William South area, located 2 km from the existing deposit, with initial results indicating 2.38 g/t gold at a depth of 13 meters, suggesting substantial mineralization potential in the region.
- Geophysical Coverage Expansion: An ongoing IP survey covering 49 kilometers is significantly expanding existing geophysical coverage, further confirming surface geochemical anomalies in a 12 km by 7 km area surrounding the deposit, highlighting broader exploration potential.
- Infrastructure Advantage: The project area benefits from excellent infrastructure, including grid power, highway access, and a fully operational 50-person camp, allowing more funds to be directed towards the expansion of mineral resources.
See More
GoldMining Inc. Reports FY GAAP EPS of -C$0.07
- Financial Overview: GoldMining Inc. reported a FY GAAP EPS of -C$0.07, indicating significant financial challenges that could undermine investor confidence and lead to stock price volatility.
- Historical Performance Comparison: This negative EPS compared to historical data suggests that the company is under pressure regarding profitability, necessitating operational improvements to restore earnings.
- Market Reaction Expectations: The negative earnings per share may raise concerns about the company's future profitability, prompting investors to reassess their investment strategies in the gold mining sector, potentially putting downward pressure on the stock price in the short term.
- Analyst Rating Impact: According to Seeking Alpha's Quant Rating, GoldMining Inc.'s financial performance may influence analysts' expectations for its future performance, thereby affecting its market positioning and investment appeal.
See More
GoldMining Inc. Files Annual Financial Statements for FY 2025
- Annual Report Release: GoldMining Inc. announced the filing of its annual financial statements and management's discussion and analysis for the fiscal year ending November 30, 2025, on February 27, 2026, providing detailed insights into the company's financial health, operations, and projects to enhance investor understanding.
- Information Access: The annual filings are available on www.sedarplus.ca, EDGAR, and the company's website, ensuring that investors can easily access the latest financial information, thereby improving transparency and trust in the company's operations.
- Company Overview: GoldMining Inc. is a public mineral exploration company focused on acquiring and developing gold assets across the Americas, and through its disciplined acquisition strategy, it now controls a diversified portfolio of resource-stage gold and gold-copper projects in Canada, the USA, Brazil, Colombia, and Peru.
- Strategic Development: The release of this annual report not only showcases the company's progress in resource development but also reflects its strategic positioning in the global gold market, aiming to attract more investor interest in its potential growth opportunities.
See More
GoldMining Updates Mineral Resource Estimate for Crucero Project
- Significant Resource Increase: The updated Mineral Resource Estimate for the Crucero Project shows an indicated resource of 42.7 million tonnes at 1.26 g/t gold equivalent, totaling 1.74 million ounces, representing a 75% increase from the 2017 estimate, which will significantly enhance the company's asset value and market appeal.
- Inclusion of Antimony: For the first time, antimony has been included in the resource estimate, contributing 25% of the indicated gold equivalent and 29% of the inferred gold equivalent, indicating the project's multi-metal potential and possibly attracting more investor interest.
- Market Price Impact: The estimate is based on a long-term gold price of $3,110 per ounce, while current spot prices are nearing $5,000 per ounce, highlighting the project's economic potential and future profitability, which could drive the company's stock price higher.
- Technical Report Submission Plan: The company plans to file the NI 43-101 technical report within 45 days, providing further details on estimation methods and procedures, which will enhance investor confidence in the project and facilitate subsequent financing.
See More
Spot Silver Continues Decline, Currently Down 6% at $67 per Ounce
- Market Performance: Silver prices have experienced a decline, dropping 6% to $67 per ounce.
- Trend Analysis: The recent downturn in silver prices indicates a potential shift in market dynamics.
See More
Sarepta Therapeutics Reports Significant Three-Year Study Results
- Clinical Trial Results: Sarepta Therapeutics reported significant three-year results from the EMBARK study, showing that patients treated with Elevidys demonstrated statistically significant efficacy in motor function assessments, leading to a 9.8% stock price increase to $23.20, indicating enhanced competitiveness in Duchenne muscular dystrophy treatment.
- Positive Market Reaction: Following the release of favorable clinical data, there was a surge in demand for Sarepta's shares, reflecting investor optimism about the biopharmaceutical sector's outlook, which may attract more capital into the industry.
- Industry Impact: Sarepta's success could inspire other biopharmaceutical companies to increase investments in rare disease research and development, thereby fostering innovation and growth across the sector.
- Investor Confidence Boost: The success story of Sarepta may bolster investor confidence in biotech stocks, particularly as market conditions continue to favor increased focus on the healthcare sector.
See More
GoldMining Initiates New Exploration Drill Program
- Drill Program Launch: GoldMining has commenced an 8,000-meter drill program at its São Jorge Project in Brazil's Tapajós gold district, aimed at following up on high-priority targets from 2025, which is expected to significantly enhance mineral resource estimates.
- High-Priority Targets: The drilling will focus on the William South area, located 2 km from the existing deposit, with initial results indicating 2.38 g/t gold at a depth of 13 meters, suggesting substantial mineralization potential in the region.
- Geophysical Coverage Expansion: An ongoing IP survey covering 49 kilometers is significantly expanding existing geophysical coverage, further confirming surface geochemical anomalies in a 12 km by 7 km area surrounding the deposit, highlighting broader exploration potential.
- Infrastructure Advantage: The project area benefits from excellent infrastructure, including grid power, highway access, and a fully operational 50-person camp, allowing more funds to be directed towards the expansion of mineral resources.
See More
GoldMining Inc. Reports FY GAAP EPS of -C$0.07
- Financial Overview: GoldMining Inc. reported a FY GAAP EPS of -C$0.07, indicating significant financial challenges that could undermine investor confidence and lead to stock price volatility.
- Historical Performance Comparison: This negative EPS compared to historical data suggests that the company is under pressure regarding profitability, necessitating operational improvements to restore earnings.
- Market Reaction Expectations: The negative earnings per share may raise concerns about the company's future profitability, prompting investors to reassess their investment strategies in the gold mining sector, potentially putting downward pressure on the stock price in the short term.
- Analyst Rating Impact: According to Seeking Alpha's Quant Rating, GoldMining Inc.'s financial performance may influence analysts' expectations for its future performance, thereby affecting its market positioning and investment appeal.
See More
GoldMining Inc. Files Annual Financial Statements for FY 2025
- Annual Report Release: GoldMining Inc. announced the filing of its annual financial statements and management's discussion and analysis for the fiscal year ending November 30, 2025, on February 27, 2026, providing detailed insights into the company's financial health, operations, and projects to enhance investor understanding.
- Information Access: The annual filings are available on www.sedarplus.ca, EDGAR, and the company's website, ensuring that investors can easily access the latest financial information, thereby improving transparency and trust in the company's operations.
- Company Overview: GoldMining Inc. is a public mineral exploration company focused on acquiring and developing gold assets across the Americas, and through its disciplined acquisition strategy, it now controls a diversified portfolio of resource-stage gold and gold-copper projects in Canada, the USA, Brazil, Colombia, and Peru.
- Strategic Development: The release of this annual report not only showcases the company's progress in resource development but also reflects its strategic positioning in the global gold market, aiming to attract more investor interest in its potential growth opportunities.
See More
GoldMining Updates Mineral Resource Estimate for Crucero Project
- Significant Resource Increase: The updated Mineral Resource Estimate for the Crucero Project shows an indicated resource of 42.7 million tonnes at 1.26 g/t gold equivalent, totaling 1.74 million ounces, representing a 75% increase from the 2017 estimate, which will significantly enhance the company's asset value and market appeal.
- Inclusion of Antimony: For the first time, antimony has been included in the resource estimate, contributing 25% of the indicated gold equivalent and 29% of the inferred gold equivalent, indicating the project's multi-metal potential and possibly attracting more investor interest.
- Market Price Impact: The estimate is based on a long-term gold price of $3,110 per ounce, while current spot prices are nearing $5,000 per ounce, highlighting the project's economic potential and future profitability, which could drive the company's stock price higher.
- Technical Report Submission Plan: The company plans to file the NI 43-101 technical report within 45 days, providing further details on estimation methods and procedures, which will enhance investor confidence in the project and facilitate subsequent financing.
See More
Spot Silver Continues Decline, Currently Down 6% at $67 per Ounce
- Market Performance: Silver prices have experienced a decline, dropping 6% to $67 per ounce.
- Trend Analysis: The recent downturn in silver prices indicates a potential shift in market dynamics.
See More
Sarepta Therapeutics Reports Significant Three-Year Study Results
- Clinical Trial Results: Sarepta Therapeutics reported significant three-year results from the EMBARK study, showing that patients treated with Elevidys demonstrated statistically significant efficacy in motor function assessments, leading to a 9.8% stock price increase to $23.20, indicating enhanced competitiveness in Duchenne muscular dystrophy treatment.
- Positive Market Reaction: Following the release of favorable clinical data, there was a surge in demand for Sarepta's shares, reflecting investor optimism about the biopharmaceutical sector's outlook, which may attract more capital into the industry.
- Industry Impact: Sarepta's success could inspire other biopharmaceutical companies to increase investments in rare disease research and development, thereby fostering innovation and growth across the sector.
- Investor Confidence Boost: The success story of Sarepta may bolster investor confidence in biotech stocks, particularly as market conditions continue to favor increased focus on the healthcare sector.
See More
